WHO ICTRP trial

The effect of Betahistine on nausea and vomiting after surgery

IRCT20200902048594N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20200902048594N1
Public title The effect of Betahistine on nausea and vomiting after surgery
Scientific title The effect of Betahistine on nausea and vomiting after Laparoscopic Cholecystectomy
Primary sponsor Islamic Azad University
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Phase 3
Countries Iran (Islamic Republic of)
Conditions postoperative nausea and vomiting. Nausea with vomiting, unspecified;R11.2
Interventions Intervention 1: Intervention group:Betahistine at a dose of 16 mg from Ecterco factory, which is given to patients 3 hours before laparoscopic cholecystectomy. Intervention 2: Control group: placebo which is prepared as an empty medicine…
Registration date Sep 22, 2020
Target size 80
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations